{"id":5058,"date":"2026-03-23T19:03:42","date_gmt":"2026-03-23T11:03:42","guid":{"rendered":"http:\/\/longzhuplatform.com\/?p=5058"},"modified":"2026-03-23T19:03:42","modified_gmt":"2026-03-23T11:03:42","slug":"dr-reddys-plans-global-semaglutide-rollout-as-patents-expire","status":"publish","type":"post","link":"http:\/\/longzhuplatform.com\/?p=5058","title":{"rendered":"Dr Reddy\u2019s Plans Global Semaglutide Rollout As Patents Expire"},"content":{"rendered":"<p><\/p> <div> <p>Dr. Reddy\u2019s Laboratories is looking to scale its presence in semaglutide as the market opened up following patent expiry, with plans to expand both in India and globally. M V Ramana, CEO \u2013 Branded Markets (India and Emerging Markets), says the company is focusing on improving access in a market where adoption remains low despite a large diabetes burden, while building capabilities across development and manufacturing. He adds that Dr. Reddy\u2019s is developing a broader portfolio across metabolic therapies, including diabetes and obesity, and is preparing for launches in multiple markets as patents expire globally. The company is also targeting a position among the top players in the segment, with emphasis on physician confidence, patient adherence and supply continuity.<\/p> <\/div> <p>Business Today, Dr Reddy&#x27;s, M V Ramana, Semaglutide, Diabetes Care, Obesity Treatment#Reddys #Plans #Global #Semaglutide #Rollout #Patents #Expire1774263822<\/p> ","protected":false},"excerpt":{"rendered":"<p>Dr. Reddy\u2019s Laboratories is looking to scale its presence in semaglutide as the market opened up following patent expiry, with plans to expand both in India and globally. M V Ramana, CEO \u2013 Branded Markets (India and Emerging Markets), says the company is focusing on improving access in a market where adoption remains low despite [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5059,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[109,18738,18736,18742,187,18737,18739,10406,521,18740,18741,4388],"class_list":["post-5058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-content-marketing","tag-business-today","tag-diabetes-care","tag-dr-reddys","tag-expire","tag-global","tag-m-v-ramana","tag-obesity-treatment","tag-patents","tag-plans","tag-reddys","tag-rollout","tag-semaglutide"],"acf":[],"_links":{"self":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts\/5058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5058"}],"version-history":[{"count":0,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts\/5058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/media\/5059"}],"wp:attachment":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5058"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}